Clemente Christopher 13D/13G Filings for Odonate Therapeutics, Inc. (ODTC)

Clemente Christopher 13D and 13G filings for Odonate Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-06-15
4:41 pm
Purchase
2022-06-13 13D Odonate Therapeutics, Inc.
ODTC
Clemente Christopher 0
63.800%
0increase
(+19.52%)
Filing